These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Direct radiolabeling of monoclonal antibodies with generator-produced rhenium-188 for radioimmunotherapy: labeling and animal biodistribution studies. Griffiths GL, Goldenberg DM, Knapp FF, Callahan AP, Chang CH, Hansen HJ. Cancer Res; 1991 Sep 01; 51(17):4594-602. PubMed ID: 1873804 [Abstract] [Full Text] [Related]
24. Radiolabelling morpholinos with 188Re tricarbonyl provides improved in vitro and in vivo stability to re-oxidation. He J, Liu C, Vanderheyden JL, Liu G, Dou S, Rusckowski M, Hnatowich DJ. Nucl Med Commun; 2004 Jul 01; 25(7):731-6. PubMed ID: 15208502 [Abstract] [Full Text] [Related]
25. Radiolabeling morpholinos with 90Y, 111In, 188Re and 99mTc. Liu CB, Liu GZ, Liu N, Zhang YM, He J, Rusckowski M, Hnatowich DJ. Nucl Med Biol; 2003 Feb 01; 30(2):207-14. PubMed ID: 12623121 [Abstract] [Full Text] [Related]
26. Endovascular beta irradiation for prevention of restenosis using solution radioisotopes: pharmacologic and dosimetric properties of rhenium-188 compounds. Knapp FF, Guhlke S, Beets AL, Lin WY, Stabin M, Amols H, Weinberger J. Cardiovasc Radiat Med; 1999 Feb 01; 1(1):86-97. PubMed ID: 11272362 [Abstract] [Full Text] [Related]
32. Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors. Müller C, Schubiger PA, Schibli R. Nucl Med Biol; 2007 Aug 01; 34(6):595-601. PubMed ID: 17707798 [Abstract] [Full Text] [Related]
33. Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs. Maina T, Nock BA, Zhang H, Nikolopoulou A, Waser B, Reubi JC, Maecke HR. J Nucl Med; 2005 May 01; 46(5):823-30. PubMed ID: 15872357 [Abstract] [Full Text] [Related]
38. Preparation and evaluation of 186/188Re-labeled antibody (A7) for radioimmunotherapy with rhenium(I) tricarbonyl core as a chelate site. Ogawa K, Kawashima H, Kinuya S, Shiba K, Onoguchi M, Kimura H, Hashimoto K, Odani A, Saji H. Ann Nucl Med; 2009 Dec 01; 23(10):843-8. PubMed ID: 19921351 [Abstract] [Full Text] [Related]
39. Development of a rhenium-186-labeled MAG3-conjugated bisphosphonate for the palliation of metastatic bone pain based on the concept of bifunctional radiopharmaceuticals. Ogawa K, Mukai T, Arano Y, Ono M, Hanaoka H, Ishino S, Hashimoto K, Nishimura H, Saji H. Bioconjug Chem; 2005 Dec 01; 16(4):751-7. PubMed ID: 16029015 [Abstract] [Full Text] [Related]